Key result
SAH-induced reverse Takotsubo cardiomyopathy patients were younger and had higher plasma epinephrine than those with typical TTC.
Observational (n=31)
No
Reverse Takotsubo cardiomyopathy associated with subarachnoid hemorrhage occurs in younger patients and is associated with higher epinephrine levels compared to typical Takotsubo, though clinical outcomes like 90-day mortality are similar.
Answers are grounded in this paper and cite their sources.
Reverse Takotsubo in SAH should not alter current management; leaves open epinephrine's role in subtype-specific trials.
Both Takotsubo cardiomyopathy (TTC) and reverse TTC (r-TTC) are characterized by reversible regional wall motion abnormalities of the heart unrelated to coronary artery pathology. It remains unclear whether and/or how r-TTC differs from TTC. Subarachnoid hemorrhage (SAH) is occasionally causative of TTC/r-TTC, and this study was conducted to detect possible differences between TTC and r-TTC associated with SAH. A single-center retrospective study was conducted on 328 consecutive SAH patients. They routinely underwent transthoracic echocardiography (TTE), ECG, and measurements of plasma catecholamines and other cardiac biomarkers within 24 h of admission. Demographic, echocardiographic, electrocardiographic and neurochemical profiles were compared between patients with TTC and r-TTC. The diagnosis of TTC/r-TTC was based on the revised Mayo Clinic Criteria. Data of 21 SAH-induced TTC and 10 SAH-induced r-TTC patients admitted between January 2009 and December 2014 were analyzed. The patients with r-TTC were significantly younger than those with TTC (51.8 ± 10.9 vs. 63.5 ± 14.4 years, p = 0.04). The former exhibited significantly higher plasma epinephrine levels than the latter (809 ± 710 vs. 380 ± 391 pg/mL, p = 0.04). Plasma norepinephrine levels did not differ significantly (2421 ± 1374 vs. 1724 ± 1591 pg/mL, p = 0.25). No significant differences were observed in other demographic/physiologic variables, echocardiographic parameters, frequency of ECG abnormalities, and 90-day mortality. Moreover, none of the patients who underwent a follow-up TTE exhibited morphologic change from one type to the other. The pathomechanisms in TTC and r-TTC may not be identical: however, distinguishing the two conditions may not have great importance from the standpoint of clinical management and prognostication.
No takes yet. Share an insight, caveat, or question.
Kumai et al. (2016) conducted an observational in Subarachnoid hemorrhage-induced Takotsubo cardiomyopathy (n=31). Reverse Takotsubo cardiomyopathy vs. Typical Takotsubo cardiomyopathy was evaluated on Plasma epinephrine levels (pg/mL) (p=0.04). SAH-induced reverse Takotsubo cardiomyopathy patients were younger and had higher plasma epinephrine than those with typical TTC.
Synapse has enriched 10 related papers. Consider them for comparative context: